Amendment 0001: Question and Answer period added. Amendment 0002: Offer due date extended to 9 September 2022. See Revised Attachment 2 (revision to Addendum to 52.212-1). Question due date extended to 26 August 2022. 1.0 This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued. 1.1. The combined synopsis is issued as a Request for Proposal (RFP) under solicitation number: W912LP-22-R-0005 1.2. This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2022-06 (26 May 2022). 1.3. Small Business Set-Aside: 100%; Applicable Size Standard is $14.5M 1.4. NAICS Code: 611699 1.5. Product or Service Code (PSC): U006 1.6. Posting Date: 10 August 2022 1.7. Response Date: 9 September 2022, 11:00 a.m. central (local) 1.8. Contracting Office: USPFO - Purchasing & Contracting, 7105 NW 70th Ave, Johnston, IA 50131 1.9. Government Points of Contact: Contracting Officer: Vicky L. Williams,
contact@example.gov and Contract Specialist: Kelsey Letcher,
contact@example.gov 1.10. Line item number(s) and items, quantities, and units of measure: 0001 Technical Instruction Services - Base Period. The contractor shall design, develop, and teach a - Development, Management & Control of Drug Informants course for the Midwest Counterdrug Training Center (MCTC). See Performance Work Statement (PWS) for details. The contractor shall provide up to 6 iterations of the course during the base period of performance (POP). 1001 Technical Instruction Services - Option 1. The contractor shall provide up to 8 iterations of the - Development, Management & Control of Drug Informants course during the Option 1 POP. 2001 Technical Instruction Services - Option 2. The contractor shall provide up to 8 iterations of the - Development, Management & Control of Drug Informants course during the Option 2 POP. 3001 Technical Instruction Services - Option 3. The contractor shall provide up to 8 iterations of the - Development, Management & Control of Drug Informants course during the Option 3 POP. 4001 Technical Instruction Services - Option 4. The contractor shall provide up to 8 iterations of the - Development, Management & Control of Drug Informants course during the Option 4 POP. 1.11. Description of requirements for the services to be acquired: See Attachment 1 - Performance Work Statement 1.12. Date(s) and place(s) of delivery and acceptance and FOB point: See Attachment 1 - Performance Work Statement 1.13. Provision 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services, and addendum applies to this acquisition. See Attachment 2 - Provisions and Clauses 1.14. Offerors shall include a completed copy of 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services with their proposal. See Attachment 2 - Provisions and Clauses 1.15. FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services applies to this acquisition. See Attachment 2 - Provisions and Clauses 1.16. FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Products and Commercial Services, applies to this acquisition. See clause below, in full text, for list of additional applicable clauses. See Attachment 2 - Provisions and Clauses 1.17. Additional contract provisions and clauses are applicable. See Attachment 2 - Provisions and Clauses 1.18. Defense Priorities and Allocations Systems (DPAS) Rating: Not rated. 1.19 Questions regarding this solicitation shall be submitted by 11:00 a.m. (local) on 26 August 2022. Questions and Answers will be consolidated on a Question and Answer document on a non-attribution basis and posted to Contract Opportunities. Offerors shall monitor Contract Opportunities frequently, as no other distribution will be made.